clinicaltrialsarena13 小时
Sensorion completes first cohort enrolment in Phase I/II gene therapy trial
Sensorion has completed subject enrolment in the first cohort of Phase I/II Audiogene trial of gene therapy injection, SENS-501.
clinicaltrialsarena3 天
China’s CDE approves Alphamab’s IND to begin Phase I/II trial of JSKN033
China NMPA's CDE has approved Alphamab Oncology’s IND for the multicentre Phase I/II JSKN033-102 trial of JSKN033.
clinicaltrialsarena6 天
XBiotech halts all rheumatology research after missing Phase II endpoints
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
clinicaltrialsarena4 天
Ractigen doses first subject in Phase I ALS treatment trial
RAG-17 is tailored for the SOD1 gene suppression in individuals with ALS having pathogenic mutations. Credit: CC7/Shutterstock. Ractigen Therapeutics has dosed the first subject in the randomised ...
clinicaltrialsarena6 天
Arrowhead doses first patient in Phase I/IIa RNA obesity therapy trial
The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment for obesity.
clinicaltrialsarena6 天
Zura Bio initiates Phase II systemic sclerosis treatment trial
Modified Rodnan Skin Score is the primary endpoint of the TibuSURE trial. Credit: Cesare Andrea Ferrari/Shutterstock. Zura Bio has initiated the double-blind Phase II TibuSURE trial to assess the ...